Response from CEO, CHAI about the Quick Start program in November 2016

Response from CEO, CHAI about the Quick Start program in November 2016

Please click here

/ News

Related Posts

20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Progress report on access to hepatitis C treatment, WHO March 2018
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Strategies to Secure Access to Generic HCV Medicines
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia